Fmoc-(R)-3-Amino-4-(4-nitro-phenyl)-butyric acid, 97%, 1g

2-Cyclopropyl-8-methylquinoline-4-carboxylic acid, 95%, 5g

N-methyl-2-(2-methylpiperidin-1-yl)ethanamine, 95.0%, 1g

(1,3-DIHYDROFURO[3,4-C]PYRIDIN-6-YL)METHANOL, 95.0%, 1g

tert-Butyl 4-(2-bromoethyl)piperazine-1-carboxylate, 95.0%, 25g

3-Amino-N-butylbenzamide, 95.0%, 5g

1-(Tetrahydropyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole>98.0%(GC)(T)1g

3-(Trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine, 95.0%, 1g

(2-Chloro-5-methoxypyridin-4-yl)boronic acid, 97%, 250mg

3,9-diazaspiro[5.5]undecane-2,4-dione dihydrochloride, 95.0%, 1g

Evaporating dishes ROTILABO® high form, 500 ml, 1 Piece

N-(2-Methoxybenzyl)oxetan-3-yl-amine, >95%, 1g

7-Amino-2,3-dihydroinden-1-one, 95.0%, 100mg